Looking forward to this.
AdAlta's (ASX:1AD) CEO and MD, Tim Oldham will host a webinar to discuss AdAlta’s new collaboration with SYNthesis BioVentures under a Memorandum of Understanding announced on Monday 8 April 2024 and general business progress | Register https://us02web.zoom.us/webinar/register/WN_86kBPnJVTja6QmLsty2i7Q#/registration… #1AD #Webinar
Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-14
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.36M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 545000 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 560699 | 4 |
View Market Depth
| Last trade - 16.13pm 13/11/2024 (20 minute delay) ? |
| 1AD (ASX) Chart |
Day chart unavailable